Condensed indole derivatives as 5HT.sub.4 -receptor antagonists
申请人:SmithKline Beecham plc
公开号:US05998409A1
公开(公告)日:1999-12-07
Compounds of formula (I) and pharmaceutically acceptable salts thereof: ##STR1## and their use as pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and CNS disorders.
CONDENSED INDOLE DERIVATIVES AS 5-HT4-RECEPTOR ANTAGONISTS
申请人:SMITHKLINE BEECHAM PLC
公开号:EP0630376B1
公开(公告)日:1999-06-02
N-[(1-Butyl-4-piperidinyl)methyl]-3,4- dihydro-2H-[1,3]oxazino[3,2-a]indole- 10-carboxamide hydrochloride: the first potent and selective 5-HT4 receptor antagonist amide with oral activity.
作者:Laramie M. Gaster、Graham F. Joiner、Frank D. King、Paul A. Wyman、Jonathan M. Sutton、Sharon Bingham、Elizabeth S. Ellis、Gareth J. Sanger、Kay A. Wardle